You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 11, November 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  Medical News
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Use of Injectable Human Fibroblasts

JEANNE ADAMS, MD
Durham, NC

Arch Otolaryngol Head Neck Surg. 1988;114(11):1228.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

At the recent spring meeting of the American Academy of Facial Plastic and Reconstructive Surgery in Palm Beach, Fla, Dr Dan Remmler, Scottsdale, Ariz, and coworkers presented data on the experimental use of cultured human fibroblasts and/or Zyderm collagen (injectable bovine collagen, Collagen Corp, Palo Alto, Calif) for soft-tissue augmentation.

Cultured human fibroblasts (HFb), Zyderm II injectable bovine collagen (Zyd), HFb and Zyd, and Zyplast-injectable, glutaraldehyde-treated, bovine collagen (Zyp) were injected into 17 athymic nude mice. Balanced salt solution was used as a control. Each mouse received 0.5 mL of each substance by subcutaneous injection; HFb, HFb and Zyd, Zyd, and balanced salt solution were injected into the dorsum, and Zyp was injected into the ventral surface. Nodular swellings resulting from the subcutaneous injections were measured immediately following injection. At ten days and nine weeks, the volume was again measured, and the implants were examined histologically.

At nine weeks, HFb . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.